Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: IMMUNANT, INC.
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Defense Advanced Research Projects Agency
Period of performance: 2021-07-15 to 2025-02-28
Current total value of award: $1498543.96
Description: DARPA SMALL BUSINESS INNOVATIVE RESEARCH II - NO COST EXTENSION FOR CLINS 0003 AND 0004.